Animal Health Active Pharmaceutical Ingredients Market Report 2022: Rising Global Pet Adoption and Rising Awareness and Spending on Animal Health Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Animal Health Active Pharmaceutical Ingredients Market Research Report by Company (Captive API and Merchant API), Indication, Synthesis, Type, End User, Region (Americas, Asia-Pacific and Europe, Middle East and Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19 Report has been added to from ResearchAndMarkets.com offer.

The global active pharmaceutical ingredients for animal health market size was estimated to be USD 14.92 billion in 2021, USD 16.11 billion in 2022, and is projected to grow at a CAGR of 8.12% to reach USD 23.84 billion. USD by 2027.

Segmentation and market coverage:

This research report categorizes Animal Health Active Pharmaceutical Ingredients to forecast revenues and analyze trends in each of the following submarkets:

  • Based on Business, the market has been studied through Captive API and Merchant API.

  • On the basis of indication, the market has been studied for anti-infectives, antiparasitics, and NSAIDs and anesthetics.

  • On the basis of synthesis, the market has been studied through biotechnology and synthesis.

  • On the basis of type, the market has been studied across brands and generics.

  • On the basis of end user, the market has been studied in pet care hospitals and retail and specialty pharmacies.

  • Based on region, the market has been studied in Americas, Asia-Pacific, Europe, Middle East & Africa. The Americas are studied in more detail through Argentina, Brazil, Canada, Mexico and the United States. The United States is studied in more detail through California, Florida, Illinois, New York, Ohio, Pennsylvania and Texas. Asia-Pacific is studied in more detail across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan and Thailand. Europe, the Middle East and Africa are studied in more detail in France, Germany, Italy, the Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, the United Arab Emirates and the United Kingdom.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market based on business strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and product satisfaction (value for money, ease of use, product features, and customer support) which helps companies make better decisions and better understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Market dynamics

Drivers

  • Growing adoption of pets around the world

  • Increase people’s awareness and spending on animal health

  • Significant growth in the number of animal health NGOs

Constraints

  • Several risk factors associated with APIs in animal health

Opportunities

  • Development of new products

  • Unmet animal needs in many countries

Challenges

  • Limited awareness and availability in low-income areas

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview

6. Animal Health Active Pharmaceutical Ingredients Market, By Company

7. Animal Health Active Pharmaceutical Ingredients Market, By Indication

8. Animal Health Active Pharmaceutical Ingredients Market, By Synthesis

9. Animal Health Active Pharmaceutical Ingredients Market, By Type

10. Animal Health Active Pharmaceutical Ingredients Market, By End User

11. Americas Animal Health Active Pharmaceutical Ingredients Market

12. Asia Pacific Animal Health Active Pharmaceutical Ingredients Market

13. Europe, Middle East and Africa Animal Health Active Pharmaceutical Ingredients Market

14. Competitive Landscape

15. Enterprise Usability Profiles

16. Appendix

Companies cited

  • Blanver Farmoquimica E Farmaceutica SA

  • Changzhou Yabang-Qh Pharmachem Co., Ltd.

  • Eli Lilly & Co.

  • Excel Industries Ltd.

  • Glenmark Pharmaceutical Ltd.

  • Huvepharma

  • Indukern, SA

  • Lonza Group AG

  • NGL Fine Chem Ltd.

  • Ningxia Tairui Pharma CO. ltd.

  • Ofichem B.V.

  • Omkar Specialty Chemicals Limited

  • ouro fino sausage animal

  • P&R SpA (Olon SpA)

  • Sanofi Winthrop Industry (CEPiA)

  • Sequent Scientific Ltd.

  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.

  • Shanghai Pharmtech Co.Ltd.

  • Zhejiang Hisun Pharmaceutical Co.Ltd

  • Zoetis Inc.

For more information about this report visit https://www.researchandmarkets.com/r/uwovo5

Boyd S. Abbott